The USPTO and FDA have Vowed to Help Generic Drug Manufacturers Enter the Marketplace

The patent system is designed as quid pro quo: inventors publicly explain how their inventions work, the government gives those inventors a limited monopoly, and then other manufacturers may compete.  However, Big pharma has been abusing the patenting system in order to try to bully generic drug manufacturers from entering the marketplace after their monopoly expires, causing excessive drug costs even after the initial patent expires for a drug.  Big […]

Read More

    CONTACT US

    I have read theDisclaimer

    Archives

    Categories

      CONTACT US

      I have read theDisclaimer